Researchers have developed a compound to tackle a molecule known as RAGE, which attacks the brain tissue of people with Alzheimer's disease.
Following previous failed attempts to block RAGE, a study by the University of Rochester and the University of Southern California has used a synthesised compound to reverse amyloid deposits and prevent inflammation in mice.
Although cautioning that the research has a long way to go, scientists believe the study is a promising step to stopping Alzheimer's disease.
Previously attempts to block RAGE where halted in a phase two human study, after concerns were raised that the compound - which was different to that being used in the current study - was unsafe in high doses.
Dr Berislav Zlokovic, a neuroscientist at the University of California, stated: "It turns out that when you inhibit RAGE, you block molecules central to creating inflammation in the brain, and that is a major problem with Alzheimer’s disease."
If the results are confirmed in larger studies, the compound could be key in helping the world better take care of its ageing population.
Find out more about Alzheimer's disease care at Barchester homes.